Notify me when SABBY MANAGEMENT, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 25 | $12,000,387 | +$7,729,276 | -$6,098,436 | +$1,630,840 | DSY, EMPD, BLNK, BTM, ABVX | 13F-HR | 17 Feb 2026, 07:24 |
| Q3 2025 | 29 | $19,266,233 | +$17,661,339 | -$10,297,062 | +$7,364,277 | DSY, EMPD, CPOP, EVEX, CANF | 13F-HR | 14 Nov 2025, 07:18 |
| Q2 2025 | 33 | $12,999,079 | +$9,525,509 | -$22,277,087 | -$12,751,578 | TPST, EOSE, LYRA, LEXX, CANF | 13F-HR | 14 Aug 2025, 07:04 |
| Q1 2025 | 36 | $23,809,396 | +$16,905,202 | -$3,153,923 | +$13,751,279 | SRFM, IWM, LLY, EOSE, KSCP | 13F-HR | 15 May 2025, 08:12 |
| Q4 2024 | 16 | $12,286,600 | +$10,371,690 | -$4,952,858 | +$5,418,832 | EOSE, SPY, IWM, VANI, BTBT | 13F-HR | 14 Feb 2025, 07:55 |
| Q3 2024 | 27 | $7,218,869 | +$4,449,739 | -$4,384,250 | +$65,489 | VANI, VLCN, HCWC, IMNN, CORZ | 13F-HR | 14 Nov 2024, 08:11 |
| Q2 2024 | 27 | $7,529,365 | +$2,765,415 | -$7,604,989 | -$4,839,574 | VANI, CORZW, RDHL, GWAV, ELTK | 13F-HR | 14 Aug 2024, 07:08 |
| Q1 2024 | 44 | $14,373,094 | +$12,717,016 | -$8,196,895 | +$4,520,121 | VANI, ELTK, CORE SCIENTIFIC INC, RDHL, GMM | 13F-HR | 15 May 2024, 07:51 |
| Q4 2023 | 46 | $11,337,713 | +$7,488,145 | -$25,669,992 | -$18,181,847 | TNXP, BCAN, MMAT, PHUN, RCON | 13F-HR | 14 Feb 2024, 06:44 |
| Q3 2023 | 66 | $31,623,439 | +$22,988,377 | -$41,369,216 | -$18,380,839 | IWM, SPY, SEEL, TC, RCON | 13F-HR | 14 Nov 2023, 07:25 |
| Q2 2023 | 68 | $27,683,729 | +$16,130,908 | -$13,807,098 | +$2,323,810 | BRAINSTORM CELL THERAPEUTICS, BIOR, SONN, AKTX, SIDU | 13F-HR | 14 Aug 2023, 17:17 |
| Q1 2023 | 72 | $26,900,241 | +$16,041,754 | -$22,780,106 | -$6,738,352 | NMTRQ, AKTX, TC, DOGZ, RCON | 13F-HR | 15 May 2023, 09:09 |
| Q4 2022 | 89 | $37,326,132 | +$15,935,851 | -$14,449,688 | +$1,486,163 | NVCT, TBLT, DOGZ, TC, IWM | 13F-HR | 14 Feb 2023, 08:40 |
| Q3 2022 | 83 | $47,374,000 | +$24,233,267 | -$26,971,409 | -$2,738,142 | BGXX, NVCT, DOGZ, BLRX, AKTX | 13F-HR | 14 Nov 2022, 09:28 |
| Q2 2022 | 76 | $53,822,000 | +$25,426,991 | -$186,594,990 | -$161,167,999 | GEVO, DOGZ, MMAT, COCP, PMCB | 13F-HR | 15 Aug 2022, 08:16 |
| Q1 2022 | 85 | $233,209,000 | +$16,254,701 | -$107,615,782 | -$91,361,081 | ION GEOPHYSICAL CORP, COCP, PMCB, BIVI, NISN | 13F-HR | 16 May 2022, 08:34 |
| Q4 2021 | 105 | $177,047,000 | +$83,173,205 | -$50,482,545 | +$32,690,660 | BTBT, BIT MINING LTD, NISN, SRNE, ESPR | 13F-HR | 14 Feb 2022, 07:54 |
| Q3 2021 | 94 | $180,040,000 | +$109,635,474 | -$54,807,622 | +$54,827,852 | BTBT, BTCM, SRNE, VXX, COCP | 13F-HR | 15 Nov 2021, 08:25 |
| Q2 2021 | 85 | $141,603,000 | +$69,197,335 | -$49,770,627 | +$19,426,708 | SRNE, COCP, RENB, ATOS, ATER | 13F-HR | 16 Aug 2021, 09:14 |
| Q1 2021 | 82 | $135,865,000 | +$124,412,637 | -$87,953,392 | +$36,459,245 | SRNE, EYES, ASXC, NBEVQ, WIMI | 13F-HR | 14 May 2021, 17:44 |
| Q4 2020 | 53 | $103,549,000 | +$55,454,075 | -$63,590,193 | -$8,136,118 | BIIB, AZN, MRNA, XWEL, CVM | 13F-HR | 16 Feb 2021, 09:00 |
| Q3 2020 | 69 | $110,558,000 | +$81,025,377 | -$47,820,401 | +$33,204,976 | BIIB, MRNA, AZN, SRNE, IMMU | 13F-HR | 16 Nov 2020, 09:09 |
| Q2 2020 | 50 | $77,017,000 | +$67,442,968 | -$23,253,332 | +$44,189,636 | BIIB, XLV, MRNA, XERS, PLL | 13F-HR | 14 Aug 2020, 08:48 |
| Q1 2020 | 57 | $28,887,000 | +$18,861,855 | -$15,427,280 | +$3,434,575 | XLV, GLD, NOVN, ENLV, OTLK | 13F-HR | 15 May 2020, 17:00 |
| Q4 2019 | 49 | $26,895,000 | +$14,571,751 | -$21,376,947 | -$6,805,196 | GLD, ONTX, ODTC, NABRIVA THERAPEUTICS PLC, GNCA | 13F-HR | 14 Feb 2020, 16:11 |
| Q3 2019 | 65 | $35,735,000 | +$16,633,689 | -$12,789,157 | +$3,844,532 | TEUM, ODTC, ATNM, CJJD, CRMD | 13F-HR | 14 Nov 2019, 18:17 |
| Q2 2019 | 65 | $38,359,000 | +$24,006,663 | -$17,865,459 | +$6,141,204 | ODTC, ATNM, AMPE, CJJD, GNCA | 13F-HR | 14 Aug 2019, 16:04 |
| Q1 2019 | 53 | $32,084,000 | +$8,457,621 | -$73,922,726 | -$65,465,105 | ODTC, BCLI, ORMP, LOOP, SOLO | 13F-HR | 15 May 2019, 17:10 |
| Q4 2018 | 86 | $93,597,000 | +$51,302,639 | -$33,045,310 | +$18,257,329 | BIIB, ESPR, XBI, BCLI, XERS | 13F-HR | 13 Feb 2019, 17:56 |
| Q3 2018 | 75 | $112,057,000 | +$25,140,771 | -$87,773,499 | -$62,632,728 | NKTR, BIIB, ODTC, XERS, UMRX | 13F-HR | 13 Nov 2018, 18:14 |
| Q2 2018 | 84 | $173,619,000 | +$83,165,221 | -$60,252,394 | +$22,912,827 | BIIB, NVO, ODTC, NKTR, XERS | 13F-HR | 14 Aug 2018, 08:48 |
| Q1 2018 | 86 | $155,579,000 | +$117,569,326 | -$112,624,620 | +$4,944,706 | BIIB, ODTC, SPY, UMRX, INCY | Restatement | 15 May 2018, 15:35 |
| Q4 2017 | 79 | $145,131,000 | +$64,673,402 | -$36,573,541 | +$28,099,861 | BMY, ODTC, ESPR, ONCE, MNKD | Restatement | 15 Feb 2018, 14:15 |
| Q3 2017 | 79 | $121,951,000 | +$87,608,807 | -$179,884,975 | -$92,276,168 | BMY, AXGT, ESPR, ONS, GWPH | 13F-HR | 14 Nov 2017, 09:32 |
| Q2 2017 | 112 | $218,004,000 | +$162,645,509 | -$77,391,583 | +$85,253,926 | BRISTOL MYERS SQUIBB, TSRO, UTHR, SGEN, BIOAQ | Restatement | 27 Sep 2017, 11:49 |
| Q1 2017 | 123 | $142,214,000 | +$52,179,902 | -$243,916,090 | -$191,736,188 | BMY, AMGN, ONS, IONS, MTFB | Restatement | 16 May 2017, 10:09 |
| Q4 2016 | 152 | $332,078,000 | +$183,360,107 | -$73,338,140 | +$110,021,967 | REGN, SRPT, AMGN, BMY, LLY | 13F-HR | 13 Feb 2017, 18:55 |
| Q3 2016 | 143 | $277,038,000 | +$70,219,450 | -$125,986,729 | -$55,767,279 | SRPT, REGN, AMGN, ONS, BMY | 13F-HR | 14 Nov 2016, 09:37 |
| Q2 2016 | 148 | $287,683,000 | +$124,986,812 | -$124,229,382 | +$757,430 | REGN, AMGN, SRPT, ABT, ACORDA THERAPEUTICS INC 1.75% | 13F-HR | 15 Aug 2016, 10:06 |
| Q1 2016 | 166 | $299,823,000 | +$194,878,392 | -$138,023,406 | +$56,854,986 | SPY, AMGN, REGN, SRPT, BIIB | 13F-HR | 13 May 2016, 16:54 |
| Q4 2015 | 152 | $286,610,000 | +$108,675,299 | -$288,748,454 | -$180,073,155 | IWM, GWPH, ACORDA THERAPEUTICS INC 1.75%, ALKS, VPCOU | 13F-HR | 16 Feb 2016, 09:37 |
| Q3 2015 | 194 | $487,739,000 | +$315,268,187 | -$163,188,110 | +$152,080,077 | IWM, BIIB, BMRN, MYL, PXD | 13F-HR | 16 Nov 2015, 10:06 |
| Q2 2015 | 137 | $394,648,000 | +$242,230,042 | -$196,687,221 | +$45,542,821 | TLT, MRK, GBSNU, XOM, MEDICINES CO 1.375% | 13F-HR | 14 Aug 2015, 11:17 |
| Q1 2015 | 123 | $353,250,000 | +$220,745,022 | -$210,053,727 | +$10,691,295 | B108PS, IWM, MEDICINES CO 1.375%, ZGNX, MBBYF | 13F-HR | 15 May 2015, 09:25 |
| Q4 2014 | 102 | $341,025,000 | +$196,071,446 | -$82,475,721 | +$113,595,725 | PFE, ACAD, B108PS, AZN, IOC | 13F-HR | 17 Feb 2015, 06:19 |
| Q3 2014 | 106 | $206,058,000 | +$137,753,649 | -$238,731,967 | -$100,978,318 | B108PS, IOC, TENX, GEVA, TSLA | Restatement | 18 Nov 2014, 16:03 |
| Q2 2014 | 100 | $331,550,000 | +$220,731,931 | -$86,369,492 | +$134,362,439 | WY, TEVA, REGN, ACAD, OXBT | 13F-HR | 14 Aug 2014, 09:58 |
| Q1 2014 | 82 | $205,819,000 | +$137,568,289 | -$105,398,900 | +$32,169,389 | TEVA, OXBT, ACAD, GILD, BPTH | 13F-HR | 13 May 2014, 17:47 |
| Q4 2013 | 76 | $167,503,000 | $0 | $0 | $0 | MNKD, TEVA, ACAD, SRPT, AEGR | 13F-HR | 13 Feb 2014, 19:03 |